Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06445517
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-05-31
Brief Title:
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and RelapsedRefractory B-Cell Lymphoma
Sponsor:
InSilico Medicine Hong Kong Limited
Organization:
InSilico Medicine Hong Kong Limited
Organization Data
Organization:
InSilico Medicine Hong Kong Limited
Class:
INDUSTRY
Study ID:
ISM8207_101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
InSilico Medicine Hong Kong Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None